全球体液采集和诊断市场研究报告 - 行业分析、规模、份额、增长、趋势及2023至2030年预测
市场调查报告书
商品编码
1305164

全球体液采集和诊断市场研究报告 - 行业分析、规模、份额、增长、趋势及2023至2030年预测

Global Body Fluid Collection And Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: | 出版商: Value Market Research | 英文 254 Pages | 商品交期: 最快1-2个工作天内

价格

据预测,全球体液采集与诊断市场需求将从2022年的334.1亿美元增至2030年的696.6亿美元,2023-2030年的复合年增长率为9.62%。

体液采集和诊断是指采集、分析和检测体内各种液体,如血液、尿液、唾液和脑脊液。进行这些检测是为了诊断和监测各种病症,包括传染病、癌症、代谢紊乱和荷尔蒙失调。体液采集和诊断涉及多个步骤,包括采集样本、准备分析样本和使用各种诊断技术分析样本。体液采集可通过各种方法进行,包括静脉穿刺、尿液采集和唾液采集。样本采集完成后,将在实验室进行处理并使用一系列诊断方法进行分析,如显微镜检查、培养和分子诊断。这些检查可提供有关体内是否存在特定物质的信息,如蛋白质、激素和酶,以及是否存在异常细胞或微生物。体液采集和诊断检测的结果可用于诊断病情、监测疾病进展和评估治疗效果。这些检测是现代医疗实践的重要组成部分,在疾病预防和管理方面发挥着重要作用。

市场动态:

需要定期进行体液检测的慢性疾病发病率不断上升,推动了对体液采集和诊断技术的需求。液体活检和新一代测序等先进诊断技术的发展提高了体液采集和诊断的准确性和效率。患者和医疗服务提供者对微创手术的采用推动了对微创体液采集方法的需求。人们对早期疾病检测重要性的认识不断提高,这推动了对体液采集和诊断技术的需求,因为这些检测有助于在疾病更易治疗的早期阶段发现疾病。许多国家政府正在实施促进早期疾病检测和改善医疗设施的倡议,这推动了体液采集与诊断市场的增长。远程医疗和虚拟会诊已变得越来越普遍,使个人更容易在家中获得体液采集和诊断服务。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰了解行业结构,评估全球竞争吸引力。此外,这些工具还对全球体液采集与诊断市场的各个细分市场进行了全面评估。体液采集与诊断行业的增长和趋势为本研究提供了整体方法。

市场细分:

体液采集与诊断市场报告的这一部分提供了国家和地区层面细分市场的详细数据,从而帮助战略家确定各自产品或服务的目标人群以及即将到来的机会。

按样本类型

  • 血液样本
  • 唾液
  • 尿液
  • 脑脊液

按产品

  • 检测/服务
  • 试剂盒和耗材
  • 仪器

按技术分类

  • 下一代测序(NGS)
  • 聚合酶链反应(PCR)
  • 荧光原位杂交(FISH)
  • 其他

按应用

  • 诊断与筛查
  • 诊断和监测
  • 治疗决策

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太、拉美以及中东和非洲地区体液采集与诊断市场的当前和未来需求。此外,报告还重点关注了所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况以及全球竞争格局的深入分析。体液采集和诊断市场的主要参与者包括赛默飞世尔科技公司、Bio-Rad实验室、Illumina公司、Guardant Health、QIAGEN、强生公司、美国实验室公司控股、Biocept公司、F. Hoffmann-La Roche Ltd.、MDxHealth SA。本节包括竞争格局的整体视图,其中包括各种战略发展,如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。

目 录

第一章:前言

  • 报告描述
    • 报告目标
    • 目标受众
    • 独特销售主张(USP)和产品
  • 研究范围
  • 研究方法
    • 市场调研流程
    • 市场调研方法

第二章:执行摘要

  • 市场亮点
  • 全球市场概况

第三章:体液采集与诊断 - 行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 行业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按样品类型的市场吸引力分析
    • 按产品的市场吸引力分析
    • 按技术分类的市场吸引力分析
    • 市场吸引力分析:按应用
    • 市场吸引力分析:按地区

第四章:价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料制造商列表
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道发展趋势

第五章:COVID-19爆发的影响分析

第六章:全球体液采集和诊断市场分析:按样品类型分类

  • 样本类型概述
  • 历史和预测数据
  • 按样品类型分析
  • 血液
  • 唾液
  • 尿液
  • 脑脊液

第七章 :全球体液采集和诊断市场分析:按产品分类

  • 产品概述
  • 历史和预测数据
  • 按产品分析
  • 检测/服务
  • 试剂盒和耗材
  • 仪器

第八章 : 全球体液采集与诊断市场分析:按技术分类

  • 技术概述
  • 历史和预测数据
  • 按技术分析
  • 下一代测序(NGS)
  • 聚合酶链反应(PCR)
  • 荧光原位杂交(FISH)
  • 其他

第九章:全球体液采集与诊断市场分析:按应用分类

  • 概述:按应用分类
  • 历史和预测数据
  • 分析:按应用
  • 诊断与筛查
  • 诊断与监测
  • 治疗决策

第10章:全球体液采集与诊断市场分析:按地区划分

  • 地区展望
  • 产品介绍
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美地区销售分析
    • 北美地区各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区各细分市场销售分析
    • 亚太地区各国销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东和非洲各细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东及非洲其他地区销售分析

第十一章 :体液采集与诊断产品企业竞争格局

  • 体液采集与诊断市场竞争格局
  • 伙伴关系/合作/协议
  • 合并与收购
  • 新产品发布
  • 其他发展

第十二章 :公司概况

  • 顶级公司份额分析
  • 市场集中度
  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Bio-Rad Laboratories
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Illumina Inc
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Guardant Health
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • QIAGEN
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Johnson & Johnson
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Laboratory Corporation of America Holdings
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Biocept Inc
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • F. Hoffmann-La Roche Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • MDxHealth SA.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展

*注:在公司概况中,财务细节和近期发展取决于可用性,如果是私营公司,则可能不包括在内。

Product Code: VMR112110594

The global demand for Body Fluid Collection And Diagnostics Market is presumed to reach the market size of nearly USD 69.66 BN by 2030 from USD 33.41 BN in 2022 with a CAGR of 9.62% under the study period 2023 - 2030.

Body fluid collection and diagnostics refer to the collection, analysis, and testing of various fluids within the body, such as blood, urine, saliva, and cerebrospinal fluid. These tests are performed to diagnose and monitor various medical conditions, including infectious diseases, cancer, metabolic disorders, and hormonal imbalances. Body fluid collection and diagnostics involve several steps, including the collection of the sample, preparation of the sample for analysis, and analysis of the sample using various diagnostic techniques. The collection of body fluids can be done through various methods, including venipuncture, urine collection, and saliva collection. Once the sample has been collected, it is processed and analyzed in a laboratory using a range of diagnostic methods, such as microscopy, culture, and molecular diagnostics. These tests can provide information related to the presence of specific substances in the body, such as proteins, hormones, and enzymes, as well as the presence of abnormal cells or microorganisms. The results of body fluid collection and diagnostics tests can be used to diagnose medical conditions, monitor the progression of any disease, and evaluate the effectiveness of treatments. These tests are an essential part of modern medical practice and play a vital role in disease prevention and management. 

Market Dynamics:

The increasing incidence of chronic diseases which require regular body fluid testing, is driving the demand for body fluid collection and diagnostics. The development of advanced diagnostic techniques and technologies, such as liquid biopsy and next-generation sequencing, has improved the accuracy and efficiency of body fluid collection and diagnostics. The adoption of minimally invasive procedures among patients and healthcare providers is driving the demand for less invasive body fluid collection methods. The awareness about the importance of early disease detection is scaling up, which is driving the demand for body fluid collection and diagnostics, as these tests can help detect diseases at an early stage when they are more treatable. Many governments are implementing initiatives to promote early disease detection and improve healthcare facilities, which is driving the growth of the body fluid collection and diagnostics market. Telemedicine and virtual consultations have become more prevalent, making it easier for individuals to access body fluid collection and diagnostic services from the comfort of their homes.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of body fluid collection and diagnostics. The growth and trends of body fluid collection and diagnostics industry provide a holistic approach to this study. 

Market Segmentation:

This section of the body fluid collection and diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Sample Type

  • Blood
  • Saliva
  • Urine
  • Cerebrospinal Fluid

By Product

  • Tests/Services
  • Kits & Consumables
  • Instruments

By Technology

  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence In Situ Hybridization (FISH)
  • Others

By Application

  • Prognostics & Screening
  • Diagnostics & Monitoring
  • Therapeutic Decision Making

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Body Fluid Collection And Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the body fluid collection and diagnostics market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Illumina Inc, Guardant Health, QIAGEN, Johnson & Johnson, Laboratory Corporation of America Holdings, Biocept Inc, F. Hoffmann-La Roche Ltd., MDxHealth SA. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BODY FLUID COLLECTION AND DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Sample Type
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Technology
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE

  • 6.1 Overview by Sample Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Sample Type
  • 6.4 Blood Historic and Forecast Sales by Regions
  • 6.5 Saliva Historic and Forecast Sales by Regions
  • 6.6 Urine Historic and Forecast Sales by Regions
  • 6.7 Cerebrospinal Fluid Historic and Forecast Sales by Regions

7 . GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET ANALYSIS BY PRODUCT

  • 7.1 Overview by Product
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Product
  • 7.4 Tests/Services Historic and Forecast Sales by Regions
  • 7.5 Kits & Consumables Historic and Forecast Sales by Regions
  • 7.6 Instruments Historic and Forecast Sales by Regions

8 . GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

  • 8.1 Overview by Technology
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Technology
  • 8.4 Next Generation Sequencing (NGS) Historic and Forecast Sales by Regions
  • 8.5 Polymerase Chain Reaction (PCR) Historic and Forecast Sales by Regions
  • 8.6 Fluorescence In Situ Hybridization (FISH) Historic and Forecast Sales by Regions
  • 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

  • 9.1 Overview by Application
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Application
  • 9.4 Prognostics & Screening Historic and Forecast Sales by Regions
  • 9.5 Diagnostics & Monitoring Historic and Forecast Sales by Regions
  • 9.6 Therapeutic Decision Making Historic and Forecast Sales by Regions

10 . GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE BODY FLUID COLLECTION AND DIAGNOSTICS COMPANIES

  • 11.1. Body Fluid Collection And Diagnostics Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF BODY FLUID COLLECTION AND DIAGNOSTICS INDUSTRY

  • 12.1. Top Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Thermo Fisher Scientific Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Bio-Rad Laboratories
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Illumina Inc
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Guardant Health
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. QIAGEN
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Johnson & Johnson
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Laboratory Corporation of America Holdings
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Biocept Inc
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. F. Hoffmann-La Roche Ltd.
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. MDxHealth SA.
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments

 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  Analysis by Sample Type (USD MN)
  •  Blood Market Sales by Geography (USD MN)
  •  Saliva Market Sales by Geography (USD MN)
  •  Urine Market Sales by Geography (USD MN)
  •  Cerebrospinal Fluid Market Sales by Geography (USD MN)
  •  Analysis Market by Product (USD MN)
  •  Tests/Services Market Sales by Geography (USD MN)
  •  Kits & Consumables Market Sales by Geography (USD MN)
  •  Instruments Market Sales by Geography (USD MN)
  •  Analysis by Technology (USD MN)
  •  Next Generation Sequencing (NGS) Market Sales by Geography (USD MN)
  •  Polymerase Chain Reaction (PCR) Market Sales by Geography (USD MN)
  •  Fluorescence In Situ Hybridization (FISH) Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis by Application (USD MN)
  •  Prognostics & Screening Market Sales by Geography (USD MN)
  •  Diagnostics & Monitoring Market Sales by Geography (USD MN)
  •  Therapeutic Decision Making Market Sales by Geography (USD MN)
  •  Global Body Fluid Collection And Diagnostics Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition

LIST OF FIGURES

  •  Research Scope of Body Fluid Collection And Diagnostics Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Body Fluid Collection And Diagnostics Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Sample Type
  •  Market Attractiveness Analysis by Product
  •  Market Attractiveness Analysis by Technology
  •  Market Attractiveness Analysis by Application
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Sample Type (USD MN)
  •  Blood Market Sales by Geography (USD MN)
  •  Saliva Market Sales by Geography (USD MN)
  •  Urine Market Sales by Geography (USD MN)
  •  Cerebrospinal Fluid Market Sales by Geography (USD MN)
  •  Global Market Analysis by Product (USD MN)
  •  Tests/Services Market Sales by Geography (USD MN)
  •  Kits & Consumables Market Sales by Geography (USD MN)
  •  Instruments Market Sales by Geography (USD MN)
  •  Global Market Analysis by Technology (USD MN)
  •  Next Generation Sequencing (NGS) Market Sales by Geography (USD MN)
  •  Polymerase Chain Reaction (PCR) Market Sales by Geography (USD MN)
  •  Fluorescence In Situ Hybridization (FISH) Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by Application (USD MN)
  •  Prognostics & Screening Market Sales by Geography (USD MN)
  •  Diagnostics & Monitoring Market Sales by Geography (USD MN)
  •  Therapeutic Decision Making Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top Company Share Analysis

 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.